280-C – Pharmacy Audits by Pharmacy Benefit Managers.
§ 280-c. Pharmacy audits by pharmacy benefit managers. 1. Definitions. As used in this section, the following terms shall have the following meanings: (a) “Pharmacy benefit manager” shall have the same meaning as in section two hundred eighty-a of this article. (b) “Pharmacy” shall mean a pharmacy that has contracted with a pharmacy benefit manager […]
281 – Official New York State Prescription Forms.
§ 281. Official New York state prescription forms. 1. In addition to the requirements of section sixty-eight hundred ten of the education law or article thirty-three of this chapter, all prescriptions written in this state by a person authorized by this state to issue such prescriptions shall be on serialized official New York state prescription […]
274 – Clinical Drug Review Program.
§ 274. Clinical drug review program. 1. In addition to the preferred drug program established by this article, the commissioner may establish a clinical drug review program. The commissioner may, from time to time, require prior authorization under such program for prescription drugs or patterns of utilization under state public health plans. When a prescriber […]
275 – Applicability of Prior Authorization to Epic.
§ 275. Applicability of prior authorization to EPIC. The panel shall, no later than April first, two thousand eight, proceed to make prior authorization under the preferred drug program and the clinical review drug program, under this article, applicable to prescriptions under EPIC. The panel shall take necessary actions consistent with this article to apply […]
276 – Education and Outreach.
§ 276. Education and outreach. The department or the panel may conduct education and outreach programs for consumers and health care providers relating to the safe, therapeutic and cost-effective use of prescription drugs and appropriate treatment practices for containing prescription drug costs. The department or the panel shall provide information as to how prescribers, pharmacists, […]
277 – Review and Reports.
§ 277. Review and reports. 1. The commissioner, in consultation with the drug utilization review board, shall undertake periodic reviews, at least annually, of the preferred drug program which shall include consideration of: (a) the volume of prior authorizations being handled, including data on the number and characteristics of prior authorization requests for particular prescription […]
278 – Prescription Drug Retail Price Lists.
§ 278. Prescription drug retail price lists. 1. The department shall make prescription drug retail price lists of pharmacies, with the name and address of each pharmacy, available to the public in a database on its website at all times. The website shall enable consumers to search the database for drug retail prices of pharmacies […]
278-A – Exceptions to Drug Prescription Supply During an Emergency.
§ 278-a. Exceptions to drug prescription supply during an emergency. The commissioner shall promulgate a list of prescription drugs that shall not be subject to subsection (c) of section three thousand two hundred forty-two and subsection (c) of section four thousand three hundred twenty-nine of the insurance law. Such list shall include, but not be […]
279 – Prescriber Education.
§ 279. Prescriber education. The department shall develop in collaboration with an academic institution a program designed to provide prescribers with an evidence-based, non-commercial source of the latest objective information about pharmaceuticals. Information shall be presented to prescribers by specially-trained pharmacists, nurses or other health professionals to assist the prescriber in making appropriate therapeutic recommendations.
280 – Medicaid Drug Cap.
§ 280. Medicaid drug cap. 1. The legislature hereby finds and declares that there is a significant public interest for the Medicaid program to manage drug costs in a manner that ensures patient access while providing financial stability for the state and participating providers. Since two thousand eleven, the state has taken significant steps to […]